Alan S. Coates

1983–2023 年に発表

117
論文数
41,962
被引用数
95
h 指数
117
i10 指数

被引用数

Alan S. Coates の年別被引用数1974 年: 被引用 3 件1980 年: 被引用 1 件1981 年: 被引用 1 件1983 年: 被引用 1 件1984 年: 被引用 2 件1985 年: 被引用 6 件1986 年: 被引用 3 件1987 年: 被引用 5 件1988 年: 被引用 6 件1989 年: 被引用 9 件1990 年: 被引用 15 件1991 年: 被引用 17 件1992 年: 被引用 28 件1993 年: 被引用 24 件1994 年: 被引用 21 件1995 年: 被引用 29 件1996 年: 被引用 27 件1997 年: 被引用 51 件1998 年: 被引用 28 件1999 年: 被引用 55 件2000 年: 被引用 79 件2001 年: 被引用 97 件2002 年: 被引用 123 件2003 年: 被引用 163 件2004 年: 被引用 186 件2005 年: 被引用 208 件2006 年: 被引用 212 件2007 年: 被引用 277 件2008 年: 被引用 279 件2009 年: 被引用 280 件2010 年: 被引用 271 件2011 年: 被引用 291 件2012 年: 被引用 266 件2013 年: 被引用 314 件2014 年: 被引用 278 件2015 年: 被引用 306 件2016 年: 被引用 335 件2017 年: 被引用 294 件2018 年: 被引用 260 件2019 年: 被引用 1,014 件2020 年: 被引用 1,078 件2021 年: 被引用 896 件2022 年: 被引用 740 件2023 年: 被引用 499 件2024 年: 被引用 796 件2025 年: 被引用 336 件2026 年: 被引用 9 件1975〜1979 年は被引用が無いため表示していません1982 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,785 件、この内訳の 21.7%中国: 引用元論文 1,082 件、この内訳の 8.4%イタリア: 引用元論文 888 件、この内訳の 6.9%イギリス: 引用元論文 837 件、この内訳の 6.5%ドイツ: 引用元論文 672 件、この内訳の 5.2%カナダ: 引用元論文 462 件、この内訳の 3.6%オーストラリア: 引用元論文 449 件、この内訳の 3.5%フランス: 引用元論文 441 件、この内訳の 3.4%スイス: 引用元論文 419 件、この内訳の 3.3%オランダ: 引用元論文 396 件、この内訳の 3.1%ベルギー: 引用元論文 338 件、この内訳の 2.6%日本: 引用元論文 326 件、この内訳の 2.5%
0%21.7%その他 29.3%

分野

  • Medicine46.6%
  • Biochemistry, Genetics and Molecular Biology44.5%
  • Computer Science1.8%
  • Immunology and Microbiology1.5%
  • Economics, Econometrics and Finance0.9%
  • Engineering0.9%
  • その他3.8%

トピック

  • Breast Cancer Treatment Studies13.5%
  • Breast Lesions and Carcinomas5%
  • HER2/EGFR in Cancer Research4.4%
  • Estrogen and related hormone effects4%
  • Advanced Breast Cancer Therapies3.2%
  • Cancer Risks and Factors2.4%
  • その他67.5%

共著者

全論文

検索で開く
  1. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Sibylle Loibl, Monica Morrow, Moïse Namer, C. Kent Osborne, Ann H. Partridge, Frédérique Penault‐Llorca, Charles M. Perou, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Michael Untch, Giuseppe Viale, Toru Watanabe, Nicholas Wilcken, Eric P. Winer, William C. Wood - Annals of Oncology 2013 被引用: 3,715

  2. Strategies for subtypes—dealing with the diversity of breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011

    著者: , , , , , - Annals of Oncology 2011 被引用: 3,881

  3. Long-term outcomes for neoadjuvant versus adjuvant chemotherapy in early breast cancer: meta-analysis of individual patient data from ten randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mitch Dowsett, Frances Duane, Vaughan Evans, Marianne Ewertz, Bernard Fisher, John Forbes, Leslie G. Ford, J.-C. Gazet, Richard D. Gelber, Lucy Gettins, Luca Gianni, Michael Gnant, Jon Godwin, Aron Goldhirsch, Pamela J. Goodwin, Richard Gray, Daniel F. Hayes, Catherine Hill, James N. Ingle, Reshma Jagsi, R. Jakesz, Sam James, Wolfgang Janni, Hui Liu, Zulian Liu, Caroline Lohrisch, Sibylle Loibl, Liz MacKinnon, Andreas Makris, Eleftherios P. Mamounas, Gurdeep Mannu, Miguel Martín, S. Mathoulin, L. Mauriac, Paul McGale, Theresa McHugh, Philip Morris, Hirofumi Mukai, Larry Norton, Yasuo Ohashi, Ivo A. Olivotto, Soon Young Paik, Hongchao Pan, Richárd Pető, Martine Piccart, Lori J. Pierce, Philip Poortmans, Trevor J. Powles, K.I. Pritchard, Joseph Ragaz, Vinod Raina, Peter M. Ravdin, Simon Read, Meredith M. Regan, J.F.R. Robertson, Emiel J. Rutgers, Suzy Scholl, Dennis J. Slamon, Lidija Sölkner, Joseph A. Sparano, Seth M. Steinberg, Rosemary Sutcliffe, Sandra M. Swain, Carolyn Taylor, Andrew Tutt, Pinuccia Valagussa, Cornelis J.�H. van de Velde, Jos A. van der Hage, Giuseppe Viale, Gϋnter von Minckwitz ほか 10 名 - The Lancet Oncology 2017 被引用: 1,133

  4. Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clifford A. Hudis, James N. Ingle, Jacek Jassem, Zefei Jiang, Per Karlsson, Monica Morrow, Roberto Orecchia, C. Kent Osborne, Ann H. Partridge, Lorena de la Peña, Martine Piccart, Kathleen I. Pritchard, Emiel J. Rutgers, Felix Sedlmayer, Semiglazov Vf, Zhi‐Ming Shao, Ian Smith, Beat Thürlimann, Masakazu Toi, Andrew Tutt, Giuseppe Viale, Gϋnter von Minckwitz, Toru Watanabe, Timothy J. Whelan, Eric P. Winer, Binghe Xu - Annals of Oncology 2015 被引用: 1,837

  5. Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V

    著者: , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 623

  6. Pembrolizumab plus trastuzumab in trastuzumab-resistant, advanced, HER2-positive breast cancer (PANACEA): a single-arm, multicentre, phase 1b–2 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Alan S. Coates, Aron Goldhirsch, Per Karlsson, Ingrid Kössler, Stamatina Fournarakou, Adriana Gasca, Rita Pfister, Sabrina Ribeli-Hofmann, Magdelena Weber, Daniela Celotto, Carmen Comune, M. Frapolli, Magdalena Sánchez-Hohl, Hui Huang, Caitlin Mahoney, Karen N. Price, Karolyn Scott, Holly Shaw, Susan M. Fischer, Mónica Greco, Colleen King, Stefania Andrighetto, Martine Piccart, Heather E. Findlay, Michelle Jenkins, Vassiliki Karantza, Jaime Mejia, Patrick Schneier - The Lancet Oncology 2019 被引用: 477

  7. Axillary dissection versus no axillary dissection in patients with breast cancer and sentinel-node micrometastases (IBCSG 23-01): 10-year follow-up of a randomised, controlled phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Roswitha Kammler, Rudolf Maibach, Manuela Rabaglio, Karin Ribi, Heidi Roschitzki, Susanne Roux, Barbara Ruepp, Caitlin Mahoney, Karen N. Price, L. J. Blacher, Tara Scolese, Karolyn Scott, Sandra Lippert, Theresa Julia Zielinski, Mauro G. Mastropasqua, Stefania Andrighetto, Patrizia Dell’Orto, Giuseppe Renne, Giancarlo Pruneri, Silvia Dellapasqua, Monica Iorfida, Giuseppe Cancello, Emilia Montagna, Anna Cardillo, G. Peruzzotti, R. Ghisini, Alberto Luini, Umberto Veronesi, Mattia Intra, Oreste ­Gentilini, Stefano Zurrida, Giuseppe Curigliano, Franco Nolè, Roberto Orecchia, Marisa Cristina Leonardi, Paola Baratella, Camelia Chifu, Manuela Sargenti, Diana Crivellari, Sandro Morassut, Mario Mileto, Erica Piccoli, Andreas Veronesi, Marisa Donatella Magri, Angelo Buonadonna, Ezio Candiani, Antonino Carbone, Tiziana Perin, Rachele Volpe, Mario Roncadin, Mauro Arcicasa, Francesco Coran, Manuela Lagrassa, A. Recalcati, Maria Emanuela Limonta, Paolo Tricomi, P. Fenaroli, Elisabetta Candiago, Laura Cattaneo, Alberto Gianatti, Donatella Santini, Sylvie Maweja, Philippe Delvenne, Andrée Rorive, Joëlle Collignon, Jean-Rémi Garbay, Marie‐Christine Mathieu, Hanne Galatius, J Hoffmann, Peer Schousen ほか 102 名 - The Lancet Oncology 2018 被引用: 565

  8. Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Barbara Ruepp, Angelo Di Leo, Alan S. Coates, Richard D. Gelber, Aron Goldhirsch, Meredith M. Regan - New England Journal of Medicine 2018 被引用: 673

  9. Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 154

  10. Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23–01): a phase 3 randomised controlled trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2013 被引用: 1,229

  11. Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Richard D. Gelber, Aron Goldhirsch, Prudence A. Francis - New England Journal of Medicine 2014 被引用: 747

  12. Adjuvant Ovarian Suppression in Premenopausal Breast Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2014 被引用: 727

  13. Patterns of Recurrence and Outcome According to Breast Cancer Subtypes in Lymph Node–Negative Disease: Results From International Breast Cancer Study Group Trials VIII and IX

    著者: , , , , , , , , , , - Journal of Clinical Oncology 2013 被引用: 343

  14. Distinct Clinical and Prognostic Features of Infiltrating Lobular Carcinoma of the Breast: Combined Results of 15 International Breast Cancer Study Group Clinical Trials

    著者: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2008 被引用: 497

  15. Absolute Improvements in Freedom From Distant Recurrence to Tailor Adjuvant Endocrine Therapies for Premenopausal Women: Results From TEXT and SOFT

    著者: , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2019 被引用: 150

  16. Treatment Adherence and Its Impact on Disease-Free Survival in the Breast International Group 1-98 Trial of Tamoxifen and Letrozole, Alone and in Sequence

    著者: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 253

  17. Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 58

  18. Treatment Efficacy, Adherence, and Quality of Life Among Women Younger Than 35 Years in the International Breast Cancer Study Group TEXT and SOFT Adjuvant Endocrine Therapy Trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 148

  19. Meta-Analysis of Breast Cancer Outcomes in Adjuvant Trials of Aromatase Inhibitors Versus Tamoxifen

    著者: , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2009 被引用: 815

  20. Patient-reported outcomes with adjuvant exemestane versus tamoxifen in premenopausal women with early breast cancer undergoing ovarian suppression (TEXT and SOFT): a combined analysis of two phase 3 randomised trials

    著者: , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2015 被引用: 179

  21. Identifying breast cancer patients at risk for Central Nervous System (CNS) metastases in trials of the International Breast Cancer Study Group (IBCSG)

    著者: , , , , , , , , , , , , , , - Annals of Oncology 2006 被引用: 412

  22. Relative Effectiveness of Letrozole Compared With Tamoxifen for Patients With Lobular Carcinoma in the BIG 1-98 Trial

    著者: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2015 被引用: 199

  23. Absolute Benefit of Adjuvant Endocrine Therapies for Premenopausal Women With Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Early Breast Cancer: TEXT and SOFT Trials

    著者: , , , , , , , , , , , , , , - Journal of Clinical Oncology 2016 被引用: 182

  24. Obesity and Risk of Recurrence or Death After Adjuvant Endocrine Therapy With Letrozole or Tamoxifen in the Breast International Group 1-98 Trial

    著者: , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2012 被引用: 133